Autoimmunity Highlights

Aims & Scope

Autoimmunity Highlights publishes papers related to the diverse aspects of autoimmunity, acting as a bridge between the clinic, the laboratory and the specialists who are involved in the complex world of autoimmunity diagnosis.

The journal focuses on pathogenesis, immunology, genetics, molecular biology, diagnostic auto-antibody tests, epidemiology, pathophysiology and the treatment of autoimmune diseases.

Special, but not exclusive, attention will be given to new challenges such as genetics, molecular biology, genomics and proteomics, point-of-care testing (POCT), information technology and communication (ITC) and health economics.

View Aims & Scope

---

Metrics & Ranking

SJR (SCImago Journal Rank)

Year	Value
2024	1.413

Quartile

Year	Value
2024	Q1

Journal Rank

Year	Value
2024	2645

Journal Citation Indicator

Year	Value
2024	43

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Chemiluminescent immunoassay technology: what does it change in autoantibody detection?

  Citation: 197

  Authors: Luigi, Desré Ethel, Nicola

• Behçet’s disease physiopathology: a contemporary review

  Citation: 164

  Authors: Mohamad J., David, Marlene, David, Adrien, Patrice

• Next-generation anti-CD20 monoclonal antibodies in autoimmune disease treatment

  Citation: 155

  Authors: Fanny Huynh, Elizabeth A., Yang

• International consensus on ANA patterns (ICAP): the bumpy road towards a consensus on reporting ANA results

  Citation: 129

  Authors: Jan, Carlos A., Ignacio, Orlando Gabriel, Wilson, Paulo Luiz Carvalho, Marvin J., Manfred, Tsuneyo, Minoru, Luis E. C., Edward K. L., Karsten

• Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options

  Citation: 122

  Authors: Athina, Efthimios, Artemios, Maria, Vasileios, Zisis, Athina-Maria, Ioannis, Christos, Georgios, Georgia, Nikolaos, Dimitrios P., Georgios M.

• Myositis autoantibodies and clinical phenotypes

  Citation: 107

  Authors: Anna, Elisabetta, Marianna, Franco, Micaela, Andrea

• Associations between HLA and autoimmune neurological diseases with autoantibodies

  Citation: 93

  Authors: Sergio, Alberto, Jérôme

• Transformation of fibroblast‐like synoviocytes in rheumatoid arthritis; from a friend to foe

  Citation: 92

  Authors: Mohammad Javad, Jafar, Saeed, Mohammad Naghi, Arash Sharafat, Ahmadreza, Elham, Mahdi

• Reactive oxygen species in organ-specific autoimmunity

  Citation: 90

  Authors: Giulia, Jason, Daniel, Joudeh B., Patrizio

• The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications

  Citation: 80

  Authors: Beatrice, Angela, Marco S., Carlo

---